Literature DB >> 12956041

Group B streptococcal antibiotic resistance patterns in pregnant women.

Robert J Stiller1, Linda Padilla, Ronika Choudhary, Thomas Tinghitella, Steven Laifer.   

Abstract

Group B Streptococcal (GBS) antibiotic susceptibility studies were performed in 95 pregnant women in Bridgeport, Connecticut. Testing for penicillin, ampicillin, cefazolin, and clindamycin sensitivity was performed. Resistance to clindamycin was seen in 5% of isolates. All isolates were susceptible to penicillin, ampicillin, and cefazolin. Clindamycin sensitivity testing should be performed in patients who are allergic to penicillin. GBS remained uniformly susceptible to penicillin and first generation cephalosporins during this study period.

Entities:  

Mesh:

Year:  2003        PMID: 12956041

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  4 in total

1.  High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital.

Authors:  Ephraim E Back; Elisa J O'Grady; Joshua D Back
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.

Authors:  V Lavergne; M Laverdière; A Duchesne; C Béliveau; J Delorme; A Di Zazzo; A C Labbé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

3.  Synergistic effect between two bacteriocin-like inhibitory substances produced by Lactobacilli Strains with inhibitory activity for Streptococcus agalactiae.

Authors:  Francisco O Ruíz; Gisela Gerbaldo; María J García; Walter Giordano; Liliana Pascual; Isabel L Barberis
Journal:  Curr Microbiol       Date:  2012-01-10       Impact factor: 2.188

4.  Patterns of antibiotic resistance among group B streptococcus isolates: 2001-2004.

Authors:  Lubna Chohan; Lisa M Hollier; Karen Bishop; Charles C Kilpatrick
Journal:  Infect Dis Obstet Gynecol       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.